Home » Pfizer Wins FDA Panel's Backing for Kidney-Cancer Treatment
Pfizer Wins FDA Panel's Backing for Kidney-Cancer Treatment
Pfizer Inc., the world's biggest drugmaker, won a U.S. panel's backing for an experimental medicine for advanced kidney cancer in patients who have failed prior treatments.
Businessweek
Businessweek
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May